Home › Trial NCT06223659
EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers
- Trial IDNCT06223659
- StatusRecruiting
- PhasePhase 2
- Study typeInterventional
- SponsorOhio State University Comprehensive Cancer Center
- Enrollment100
- Start date2023-12-19
- ConditionsCutaneous Melanoma · Merkel Cell Carcinoma · Skin Squamous Cell Carcinoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.